Dissenting Views
[To accompany H.R. 4822]
The Committee on Ways and Means, to whom was referred the
bill (H.R. 4822) to improve price transparency with respect to
certain health care services, and for other purposes, having
considered the same, reports favorably thereon with an
amendment and recommends that the bill as amended do pass.
CONTENTS
Page
I. SUMMARY AND BACKGROUND.......................................... 37
A. Purpose and Summary................................. 37
B. Background and Need for Legislation................. 37
C. Legislative History................................. 40
D. Designated Hearing.................................. 40
II. EXPLANATION OF THE BILL......................................... 41
A. Price Transparency Act of 2023...................... 41
III. VOTE OF THE COMMITTEE........................................... 62
IV. BUDGET EFFECTS OF THE BILL...................................... 65
A. Committee Estimate of Budgetary Effects............. 65
B. Statement Regarding New Budget Authority and Tax
Expenditures Budget Authority...................... 65
V. OTHER MATTERS TO BE DISCUSSED UNDER THE RULES OF THE HOUSE...... 66
A. Committee Oversight Findings and Recommendations.... 66
B. Statement of General Performance Goals and
Objectives......................................... 66
C. Information Relating to Unfunded Mandates........... 66
D. Congressional Earmarks, Limited Tax Benefits, and
Limited Tariff Benefits............................ 66
E. Duplication of Federal Programs..................... 66
VI. CHANGES IN EXISTING LAW MADE BY THE BILL, AS REPORTED........... 66
A. Changes in Existing Law Proposed by the Bill, as
Reported........................................... 66
VII. DISSENTING VIEWS............................................... 394
The amendment is as follows:
Strike all after the enacting clause and insert the
following:
SECTION 1. SHORT TITLE; TABLE OF CONTENTS.
(a) Short Title.--This Act may be cited as the ``Health Care Price
Transparency Act of 2023''.
(b) Table of Contents.--The table of contents for this Act is as
follows:
Sec. 1. Short title; table of contents.
TITLE I--HEALTH CARE PRICE TRANSPARENCY FOR PATIENTS
Sec. 101. Requiring certain facilities under the Medicare program to
disclose certain information relating to charges and prices.
Sec. 102. Promoting health coverage price transparency.
Sec. 103. Oversight of pharmacy benefits manager services.
Sec. 104. Reports on health care transparency tools and data
requirements.
Sec. 105. Report on integration in Medicare.
TITLE II--FAIR PRICES FOR PATIENTS
Sec. 201. Limitation on cost sharing to net price amount under Medicare
part D.
Sec. 202. Requiring a separate identification number and an attestation
for each off-campus outpatient department of a provider.
Sec. 203. Parity in Medicare payments for hospital outpatient
department services furnished off-campus.
TITLE III--PATIENT-FOCUSED INVESTMENTS
Sec. 301. Establishing requirements with respect to the use of prior
authorization under Medicare Advantage plans.
Sec. 302. Extension of certain direct spending reductions.
TITLE I--HEALTH CARE PRICE TRANSPARENCY FOR PATIENTS
SEC. 101. REQUIRING CERTAIN FACILITIES UNDER THE MEDICARE PROGRAM TO
DISCLOSE CERTAIN INFORMATION RELATING TO CHARGES
AND PRICES.
(a) In General.--Part E of title XVIII of the Social Security Act (42
U.S.C. 1395x et seq.) is amended by adding at the end the following new
section:
``SEC. 1899C. HEALTH CARE PROVIDER PRICE TRANSPARENCY.
``(a) Hospital Price Transparency.--
``(1) In general.--Beginning January 1, 2026, each specified
hospital (as defined in paragraph (6)) that receives payment
under this title for furnishing items and services shall comply
with the price transparency requirement described in paragraph
(2).
``(2) Requirement described.--
``(A) In general.--For purposes of paragraph (1), the
price transparency requirement described in this
paragraph is, with respect to a specified hospital,
that such hospital, in accordance with a method and
format established by the Secretary under subparagraph
(C), compile and make public (without subscription and
free of charge) for each year--
``(i) one or more lists, in a format
specified by the Secretary (which may be a
machine-readable format), of the hospital's
standard charges (including the information
described in subparagraph (B)) for each item
and service furnished by such hospital; and
``(ii) information in a consumer-friendly
format (as specified by the Secretary)--
``(I) on the hospital's prices
(including the information described in
subparagraph (B)) for as many of the
Centers for Medicare & Medicaid
Services-specified shoppable services
that are furnished by the hospital, and
as many additional hospital-selected
shoppable services (or all such
additional services, if such hospital
furnishes fewer than 300 shoppable
services) as may be necessary for a
combined total of at least 300
shoppable services; and
``(II) that includes, with respect to
each Centers for Medicare & Medicaid
Services-specified shoppable service
that is not furnished by the hospital,
an indication that such service is not
so furnished.
``(B) Information described.--For purposes of
subparagraph (A), the information described in this
subparagraph is, with respect to standard charges and
prices (as applicable) made public by a specified
hospital, the following:
``(i) A description of each item or service,
accompanied by, as applicable, the Healthcare
Common Procedure Coding System code, the
diagnosis-related group, the national drug
code, or other identifier used or approved by
the Centers for Medicare & Medicaid Services.
``(ii) The gross charge, expressed as a
dollar amount, for each such item or service,
when provided in, as applicable, the inpatient
setting and outpatient department setting.
``(iii) The discounted cash price, expressed
as a dollar amount, for each such item or
service when provided in, as applicable, the
inpatient setting and outpatient department
setting (or, in the case no discounted cash
price is available for an item or service, the
median price charged by the hospital for such
item or service when provided in such settings
for the previous three years, expressed as a
dollar amount).
``(iv) Any other information the Secretary
may require for purposes of promoting public
awareness of specified hospital standard
charges or prices in advance of receiving an
item or service from such a hospital, except
information that is duplicative of any other
reporting requirement under this section. Such
information may include any current payer-
specific negotiated charges, clearly associated
with the name of the third party payer and plan
and expressed as a dollar amount, that apply to
each such item or service when provided in, as
applicable, the inpatient setting and
outpatient department setting.
``(C) Method and format.--Not later than January 1,
2026, the Secretary shall establish one or more methods
and formats for specified facilities to use in
compiling and making public standard charges and prices
(as applicable) pursuant to subparagraph (A). Any such
method and format--
``(i) may be similar to any template made
available by the Centers for Medicare &
Medicaid Services as of the date of the
enactment of this subparagraph;
``(ii) shall meet such standards as
determined appropriate by the Secretary in
order to ensure the accessibility and usability
of such charges and prices; and
``(iii) shall be updated as determined
appropriate by the Secretary, in consultation
with stakeholders.
``(3) Deemed compliance with shoppable services requirement
for hospitals with a price estimator tool.--
``(A) In general.--With respect to each year until
the effective date of regulations implementing the
provisions of sections 2799A-1(f) and 2799B-6 of the
Public Health Service Act (relating to advanced
explanations of benefits), including regulations on
establishing data transfer standards to effectuate such
provisions, a specified hospital shall be deemed to
have complied with the requirement described in
paragraph (2)(A)(ii)(I) (relating to shoppable
services) if such hospital maintains a price estimator
tool described in subparagraph (B).
``(B) Price estimator tool described.--For purposes
of subparagraph (A), the price estimator tool described
in this subparagraph is, with respect to a specified
hospital, a tool that meets the following requirements:
``(i) Such tool allows an individual to
immediately obtain a price estimate (taking
into account whether such individual is covered
under any plan, coverage, or program described
in clause (iv)(III)) and the discounted cash
price charged by a specified hospital, for each
Centers for Medicare & Medicaid Services-
specified shoppable service that is furnished
by such hospital, and for each additional
shoppable service as such hospital may select,
such that price estimates are available through
such tool for at least 300 shoppable services
(or for all such services, if such hospital
furnishes fewer than 300 shoppable services).
``(ii) Such tool allows an individual to
obtain such an estimate by billing code and by
service description.
``(iii) Such tool is prominently displayed on
the public internet website of such hospital.
``(iv) Such tool does not require an
individual seeking such an estimate to create
an account or otherwise input personal
information, except that such tool may require
that such individual provide information
specified by the Secretary, which may include
the following:
``(I) The name of such individual.
``(II) The date of birth of such
individual.
``(III) In the case such individual
is covered under a group health plan,
group or individual health insurance
coverage, a Federal health care
program, or the program established
under chapter 89 of title 5, United
States Code, an identifying number
assigned by such plan, coverage, or
program to such individual.
``(IV) In the case of an individual
described in subclause (III), an
indication as to whether such
individual is the primary insured
individual under such plan, coverage,
or program (and, if such individual is
not the primary insured individual, a
description of the individual's
relationship to such primary insured
individual).
``(V) Any other information specified
by the Secretary.
``(v) Such tool contains a statement
confirming the accuracy and completeness of
information presented through such tool as of
the date such request is made.
``(vi) Such tool meets any other requirement
specified by the Secretary.
``(4) Monitoring compliance.--The Secretary shall, through
notice and comment rulemaking and in consultation with the
Inspector General of the Department of Health and Human
Services, establish a process to monitor compliance with this
subsection. Such process shall ensure that each specified
hospital's compliance with this subsection is reviewed not less
frequently than once every 3 years.
``(5) Enforcement.--
``(A) In general.--In the case of a specified
hospital that fails to comply with the requirements of
this subsection--
``(i) the Secretary shall notify such
hospital of such failure not later than 30 days
after the date on which the Secretary
determines such failure exists; and
``(ii) upon request of the Secretary, the
hospital shall submit to the Secretary, not
later than 45 days after the date of such
request, a corrective action plan to comply
with such requirements.
``(B) Civil monetary penalty.--
``(i) In general.--In addition to any other
enforcement actions or penalties that may apply
under another provision of law, a specified
hospital that has received a notification under
subparagraph (A)(i) and fails to comply with
the requirements of this subsection by the date
that is 90 days after such notification (or, in
the case of such a hospital that has submitted
a corrective action plan described in
subparagraph (A)(ii) in response to a request
so described, by the date that is 90 days after
the Secretary identifies the failure of such
hospital to satisfactorily complete such
corrective action plan) shall be subject to a
civil monetary penalty of an amount specified
by the Secretary for each subsequent day during
which such failure is ongoing. Such amount
shall not exceed--
``(I) in the case of a specified
hospital that is a hospital or critical
access hospital with 30 or fewer beds,
$300 per day; and
``(II) in the case of any specified
hospital and except as provided in
clause (iii), $2,000,000 for a 1-year
period.
``(ii) Increase authority.--In applying this
subparagraph with respect to violations
occurring in 2029 or a subsequent year, the
Secretary may through notice and comment
rulemaking increase--
``(I) the limitation on the per day
amount of any penalty applicable to a
specified hospital that is a hospital
or critical access hospital with 30 or
fewer beds under clause (i)(I);
``(II) the limitation on the amount
of any penalty applicable for a 1-year
period under clause (i)(II); and
``(III) the limitation on the
increase of any penalty applied under
clause (iii).
``(iii) Persistent noncompliance.--In the
case of a specified hospital (other than a
specified hospital that is a hospital or
critical access hospital with 30 or fewer beds)
that the Secretary has determined to be
knowingly and willfully noncompliant with the
provisions of this subsection two or more times
during a 1-year period, the Secretary may
increase any p
Committee Action
The Committee on Ways and Means marked up H.R. 4822, the
``Price Transparency Act of 2023,'' on July 26, 2023, and
ordered the bill, as amended, favorably reported (with a quorum
being present).
D. Designated Hearing
Pursuant to clause 3(c)(6) of rule XIII, the following
hearings were used to develop and consider H.R. 4822:
(1) Committee on Ways and Means Full Committee
Hearing ``Health Care Price Transparency: A Patient's
Right to Know.''
(2) Committee on Ways and Means Health Sub-Committee
Hearing, ``Why Health Care is Unaffordable:
Anticompetitive and Consolidated Markets.''
II. EXPLANATION OF THE BILL
A. Price Transparency Act of 2023
PRESENT LAW
Section 101
Hospital Price Transparency
Under the Trump hospital price transparency rule
promulgated pursuant to Sec. 2718(e) of the PHSA, hospitals are
required to publish prices of medical services in two formats.
The first is a machine-readable file containing the following
information related to prices for services: gross prices, cash
prices, payer-specific negotiated rates, and the de-identified
maximum and minimum negotiated rates. The second format is a
consumer-friendly display of prices for at least 300 shoppable
services. A hospital may provide an online price estimator tool
in lieu of publishing prices in the second, consumer-friendly
format. CMS will send noncompliant hospitals a written warning
notice detailing the specific violation(s). Generally, if
noncompliance continues after the notice, CMS will request that
the hospital submit a corrective action plan (CAP) within 45
days of the request, which must be completed within 90 days. If
noncompliance persists, or if a hospital fails to submit a CAP
within 45 days or fails to comply within 90 days of submitting
its CAP, CMS may impose a civil monetary penalty (CMP). The CMP
amounts, initially $300 per day of noncompliance, are currently
tied to a hospital's bed count. For hospitals with 30 or fewer
beds, the maximum daily CMP is $300, for a maximum calendar
year CMP of $109,500. For hospitals with 31-550 beds, the
maximum daily CMP is $10 per bed per day, a range of $310-
$5,500. This provides for a maximum calendar year CMP between
$113,150 and $2,007,500. For hospitals with 550 or more beds,
the maximum daily CMP is $5,500, providing for a maximum
calendar year CMP of $2,007,500.
Ambulatory Surgical Center Price Transparency
Under current law, ambulatory surgical centers are not
required to publish their prices.
Clinical Laboratory Price Transparency
Under current law, clinical laboratories are not required
to publish their prices.
Imaging Services Price Transparency
Under current law, providers of imaging services are not
required to publish their prices.
Sec. 102
The Department of Health and Human Services is responsible
for regulating Medicare Part D Plans.
Pharmacy benefits managers (``PBMs'') are third-party
administrators that manage prescription drug benefits for
Medicare Part D plans. PBMs typically process prescription drug
claims, maintain prescription drug formularies on behalf of the
plan or issuer, contract with pharmacies for reimbursement, and
negotiate prices with drug manufacturers. Although plans and
issuers are required to provide certain patient protections as
a stipulation of participating in the Medicare Part D
prescription drug benefit program\18\ there is currently no
Federal law protecting patients from paying more than the
negotiated rate during the coverage phase.
---------------------------------------------------------------------------
\18\Provide Statute Citation.
---------------------------------------------------------------------------
Health Insurer Price Transparency
Under the Patient Protection and Affordable Care Act
(``PPACA''),\19\ individual market health insurance coverage
must meet various requirements to qualify for certification to
be offered through an Exchange (``Exchange coverage'').\20\
Among these requirements, Exchange coverage must permit
individuals to learn the amount of cost-sharing (including
deductibles, copayments, and coinsurance) under the
individual's plan or coverage that the individual would be
responsible for paying with respect to the furnishing of a
specific item or service by a participating provider in a
timely manner upon the request of the individual. At a minimum,
such information must be made available to such individual
through an internet website and such other means for
individuals without access to the internet.\21\ This
transparency requirement also applies to group health plans and
to health insurance issuers offering group or individual health
insurance coverage.\22\
---------------------------------------------------------------------------
\19\Pub. L. No. 111-148, March 23, 2010, as amended by the Health
Care and Education Reconciliation Act of 2010, Pub. L. No. 111-152,
March 30, 2010.
\20\An Exchange is established under section 1311 of the PPACA.
\21\Sec. 1311(e)(3)(C) of the PPACA. These requirements do not
apply to grandfathered coverage as provided under section 1251 of the
PPACA.
\22\Sec. 2715A of the Public Health Service Act (``PHSA''); sec.
9815.
---------------------------------------------------------------------------
In 2020, the Department of the Treasury, the Department of
Labor (``DOL''), and the Department of Health and Human
Services (``HHS'') (collectively, ``the Departments'') adopted
final rules under the authority described above imposing
additional transparency requirements on group health plans and
issuers of individual and group health insurance coverage,\23\
the Transparency in Coverage Final Rules (``TiC Final
Rules'').\24\ The TiC Final Rules require plans and issuers to
make the information described below available in the formats
described below.\25\
---------------------------------------------------------------------------
\23\The Departments cooperate on implementing analogous
requirements applicable to both group health plans and health insurance
issuers under their respective authorities. See section 104 of the
Health Insurance Portability and Accountability Act (``HIPAA'') of
1996, Pub. L. No. 104-191, August 21, 1996; Notice of Signing of a
Memorandum of Understanding among the Department of the Treasury, DOL,
and HHS, 64 Fed. Reg. 70164, December 15, 1999. For simplicity, this
discussion refers to ``plans and issuers'' when group health plans and
issuers of group and individual health insurance coverage are
collectively subject to a particular requirement.
\24\T.D. 9929, 85 Fed. Reg. 72158, Nov. 12, 2020.
\25\These requirements do not apply to health reimbursement
arrangements or other account-based plans.
---------------------------------------------------------------------------
Self Service Tool
Plans and issuers must make available to participants,
beneficiaries, and enrollees a ``self-service tool'' that
provides estimated cost-sharing information for a covered item
or service from a particular provider or providers.\26\ The
self-service tool must be available over the internet, and
plans and issuers must make the required information available
in paper form,\27\ upon request.
---------------------------------------------------------------------------
\26\The information made available must include 500 specified items
and services for plan years beginning on or after January 1, 2023, and
all items and services for plan years beginning on or after January 1,
2024.
\27\The TiC Final Rules set forth detailed requirements for the use
of the paper method.
---------------------------------------------------------------------------
Plans and issuers are required to make the following
information available:
An estimate of the participant's,
beneficiary's, or enrollee's cost-sharing liability for
a requested covered item or service;\28\
---------------------------------------------------------------------------
\28\The TiC Final Rules also include detailed provisions regarding
the reporting of information on bundled payment arrangements.
---------------------------------------------------------------------------
Accumulated amounts;\29\
---------------------------------------------------------------------------
\29\Accumulated amounts are generally defined to mean the amount of
financial responsibility a participant, beneficiary, or enroleee has
incurred at the time a request for cost-sharing information is made,
with respect to a deductible or out-of-pocket limit.
---------------------------------------------------------------------------
The in-network rate for the item or service;
The out-of-network allowed amount or any
other rate that provides a more accurate estimate of an
amount the plan or issuer will pay for the requested
covered item or service, generally reflected as a
dollar amount, if the request for cost-sharing
information is for a covered item or service furnished
by an out-of-network provider;
If applicable, notification that coverage of
a specific item or service is subject to a
prerequisite; and
A notice including specified plain language
disclaimers.
This information must be made available in plain language,
without subscription or other fee, through a self-service tool
on an internet website that provides real-time responses based
on cost-sharing information that is accurate at the time of the
request.
The tool must allow users to search for cost-sharing
information for a covered item or service provided by a
specific in-network provider or by all in-network providers by
inputting:
A billing code or a descriptive term, at the
option of the user;
The name of the in-network provider, if the
user seeks cost-sharing information with respect to a
specific in-network provider; and
Other factors utilized by the plan or issuer
that are relevant for determining the applicable cost-
sharing information (such as location of service,
facility name, or dosage).
The tool must allow users to search for an out-of-network
allowed amount, percentage of billed charges, or other rate
that provides a reasonably accurate estimate of the amount a
plan or issuer will pay for a covered item or service provided
by out-of-network providers by inputting:
A billing code or descriptive term, at the
option of the user; and
Other factors utilized by the plan or issuer
that are relevant for determining the applicable out-
of-network allowed amount or other rate (such as the
location in which the covered item or service will be
sought or provided).
The tool must allow users to refine and reorder search
results based on geographic proximity of in-network providers,
and the amount of the participant's, beneficiary's, or
enrollee's estimated cost-sharing liability for the covered
item or service, to the extent the search for cost-sharing
information for covered items or services returns multiple
results.
The TiC Final Rules also include standards to prevent
unnecessary duplication and permit a plan or issuer to satisfy
these requirements by entering into a written agreement under
which another party provides the required information, though
the plan or issuer remains ultimately responsible for providing
this information.
Machine-Readable Files
Plans and issuers must make publicly available three
machine-readable files: (1) the in-network rate machine-
readable file, which includes including price information for
in-network provider rates for covered items and services; (2)
the out-of-network allowed amount machine-readable file, which
includes information, on out-of-network allowed amounts and
billed charges for covered items and services; and (3) the
prescription-drug machine readable file, which includes
information on negotiated rates and historical net prices for
covered prescription drugs. These files must be updated on a
monthly basis.
The in-network rate machine-readable file must include the
following information, with an exception for prescription drugs
that are subject to a fee-for-service reimbursement
arrangement, in addition to plan or issuer identifying
information:
A billing code and a plain language
description for each billing code for each covered item
or service;
All applicable rates, including for bundled
payment arrangements,\30\ which must be:
---------------------------------------------------------------------------
\30\If the plan or issuer does not use negotiated rates for
provider reimbursement, then the plan or issuer should disclose derived
amounts to the extent these amounts are already calculated in the
normal course of business. If the plan or issuer uses underlying fee
schedule rates for calculating cost sharing, then the plan or issuer
should include the underlying fee schedule rates in addition to the
negotiated rate or derived amount.
---------------------------------------------------------------------------
Associated with the National
Provider Identifier (``NPI''), Taxpayer
Identification Number (``TIN''), and Place of
Service Code for each in-network provider.
Associated with the last date of
the contract term or expiration date for each
provider-specific applicable rate that applies
to each covered item or service; and
Indicated with a notation where
a reimbursement arrangement other than a
standard fee-for-service model (such as
capitation or a bundled payment arrangement)
applies.
The out-of-network allowed amount machine-readable file is
required to include, in addition to plan or issuer identifying
information:
A billing code and a plain language
description for each billing code for each covered item
or service; and
Unique out-of-network allowed amounts and
billed charges with respect to covered items or
services furnished by out-of-network providers during
the 90-day time period that begins 180 days prior to
the publication date of the machine-readable file
(except that this data must be omitted in relation to a
particular item or service and provider when inclusion
would require the reporting of out-of-network allowed
amounts in connection with fewer than 20 different
claims for payments under a single plan or coverage).
Each unique out-of-network allowed amount must be
reflected as a dollar amount and associated with the
NPI, TIN, and Place of Service Code for each out-of-
network provider.
The prescription drug machine-readable file is required to
include, in addition to plan or issuer identifying information:
The National Drug Code (``NDC''), and the
proprietary and nonproprietary name assigned to the NDC
by the Food and Drug Administration (``FDA''), for each
covered item or service under each coverage option
offered by a plan that is a prescription drug;
Negotiated rates, which must be:
Reflected as a dollar amount,
with respect to each NDC that is furnished by
an in-network provider;
Associated with the NPI, TIN,
and Place of Service Code for each in-network
provider; and
Associated with the last date of
the contract term for each provider-specific
negotiated rate that applies to each NDC; and
Historical net prices\31\ that are:
---------------------------------------------------------------------------
\31\Historical net price means the retrospective average amount a
plan or issuer paid for a prescription drug, inclusive of any
reasonably allocated rebates, discounts, chargebacks, fees, and any
additional price concessions received by the plan or issuer with
respect to the prescription drug.
---------------------------------------------------------------------------
Reflected as a dollar amount,
with respect to each NDC that is furnished by
an in-network provider;
Associated with the NPI, TIN,
and Place of Service Code for each in-network
provider; and
Associated with the 90-day time
period that begins 180 days prior to the
publication date of the machine-readable file
for each provider-specific historical net price
that applies to each NDC (except that such data
must be omitted in relation to a particular NDC
and provider when inclusion would require the
reporting of historical net prices calculated
using fewer than 20 different claims for
payment).
The machine-readable files must be available in a form and
manner as specified in guidance issued by the Departments. The
machine-readable files must be publicly available and
accessible to any person free of charge and without conditions,
such as establishment of a user account, password, or other
credentials, or submission of personally identifiable
information to access the file.
The TiC Final Rules include standards to prevent
unnecessary duplication and permit plans and issuers to satisfy
these requirements by entering into a written agreement under
which another party provides the required information, though
the plan or issuer remains ultimately responsible for providing
this information.
In addition, plans and issuers may satisfy the allowed
amount file requirement by disclosing out-of-network allowed
amounts made available by, or otherwise obtained from, an
issuer, a service provider, or other party with which the plan
or issuer has entered into a written agreement to provide the
information, provided the minimum claim threshold described
above is independently met for each item or service and for
each plan or coverage included in an aggregated file. Under
such circumstances, health insurance issuers, service
providers, or other parties with which the plan or issuer has
contracted may aggregate out-of-network allowed amounts for
more than one plan or insurance policy or contract.
Subsequent Changes in Law and Guidance
The Consolidated Appropriations Act, 2021 (``2021
CAA''),\32\ also includes transparency requirements. The 2021
CAA requires plans and issuers to offer price comparison
guidance by telephone and make available on the plan's or
issuer's website a ``price comparison tool'' that (to the
extent practicable) allows an individual enrolled under the
plan or coverage, with respect to participating providers, to
compare the amount of cost
Dissenting Views
Increasing health care consolidation combined with flawed
system design and policies that sanction monopolistic behavior
is failing patients across the health care system. Prices
increase year after year, emergency room wait times lengthen,
doctors' offices close, and quality of care suffers.
As a long-time advocate for greater transparency, I
certainly support the overarching goal of today's markup to
ensure more and better data concerning health care prices. Data
cannot directly lower costs, but with data we can identify
inefficiencies and waste of taxpayer dollars with the potential
to lower costs if policymakers show the courage to do it.
Unfortunately, what could have been a meaningful,
bipartisan product advancing new policies and strengthening
prior work has instead become a partisan effort to weaken
bipartisan legislation unanimously approved by the Energy and
Commerce Committee. This bill largely codifies what is already
required of hospitals and some insurers.
Meanwhile, some of the worst actors are shielded from any
meaningful accountability. Once again, Medicare Advantage is
given special treatment, omitted from the transparency
requirements of today's legislation. Charging over $1,500 more
per person each year than would have otherwise been spent if
the patient were in Traditional Medicare, private insurers are
making huge profits off MA. This bill continues to advantage
private insurance executives over disadvantaged health care
consumers and taxpayers.
And this legislation completely ignores the growing impact
of private equity with its rapid takeover of many health care
sectors, often resulting in soaring costs and worsening health
inequities. Despite modest, bipartisan, unanimous approval of
measures to address both Medicare Advantage and private equity
in another committee, today's legislation is silent.
Transparency can lead to better oversight, but only if it
is targeted toward the right information and the right actors
and is paired with enforcement. Unfortunately, this markup
misses the mark in addressing these issues and offers very
little toward lowering outrageous prices.
Nor does this legislation do anything to provide better
transparency into the pharmaceutical industry, let alone reduce
price gouging or even record the enormous contributions
taxpayers make as angel investors in research and development,
American taxpayers--the single largest contributors to pharma
R&D in the world.
We all want to encourage cures and treatments for dreaded
diseases long before we or a loved one face a troubling
diagnosis. But pharmaceutical monopolies and oligopolies have
been more concerned with manipulating the system to delay
competitors and extract the highest prices the sick and dying
will pay rather than create more innovative treatments.
Over a decade (2005-15), 78% of new drug patents were not
for the new cures we need, but were small modifications to
existing drugs designed to extend monopoly power and monopoly
prices. By one new estimate, about $40 billion in taxpayer
dollars were wasted in 2019 alone on drugs that violated
antitrust laws when delaying competitors.
30% percent of adults report not picking up prescriptions
or skipping doses because they could not afford their
medications. Yet nothing in this bill concerning Big Pharma.
Nothing to help the half of Americans who cannot afford a
$500 medical emergency, but will likely be charged thousands if
they receive a dreaded diagnosis, suffer a heart attack, or are
in a horrific car accident. Unlike shopping for most consumer
products, health care is absolutely essential. Patients do not
have a choice, yet they are forced to navigate a complex system
and are charged outrageous prices by a highly consolidated and
broken market.
While consumers get sticker shock and medical debt,
corporate interests get a shield from meaningful action. Moving
forward, we need bipartisan action to lower prices, not just
bigger font when prices are disclosed.
Sincerely,
Lloyd Doggett.
[all]